VANGUARD GROUP INC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 21 filers reported holding SOLENO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$377,000
-17.5%
2,035,806
-0.8%
0.00%
Q1 2022$457,000
-46.0%
2,051,851
-0.6%
0.00%
Q4 2021$846,000
-55.8%
2,064,392
-0.2%
0.00%
Q3 2021$1,912,000
-18.9%
2,068,5120.0%0.00%
Q2 2021$2,358,000
-20.1%
2,068,512
-11.7%
0.00%
Q1 2021$2,950,000
-18.6%
2,341,422
+24.7%
0.00%
Q4 2020$3,624,000
-3.9%
1,878,327
+25.0%
0.00%
Q3 2020$3,771,000
+22.7%
1,502,384
+8.5%
0.00%
Q2 2020$3,074,000
+28.9%
1,384,331
+38.3%
0.00%
Q1 2020$2,384,000
+40.1%
1,001,226
+73.0%
0.00%
Q4 2019$1,702,000
+302.4%
578,748
+105.2%
0.00%
Q3 2019$423,000
-38.1%
281,989
+15.6%
0.00%
Q2 2019$683,000
+55.2%
243,879
+14.1%
0.00%
Q1 2019$440,000
+37.5%
213,787
+14.3%
0.00%
Q4 2018$320,000
+123.8%
186,987
+183.0%
0.00%
Q3 2018$143,000
+20.2%
66,075
+30.1%
0.00%
Q2 2018$119,000
+32.2%
50,794
+1.8%
0.00%
Q1 2018$90,000
+23.3%
49,887
+23.2%
0.00%
Q4 2017$73,00040,4840.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders